Withings was once a free company, and it released a number of adorable products under the Activité and Steel lines back through 2016. The company was then acquired by Nokia. The company failed to integrate wearables into its long-term focus. After releasing minor iterations of Withings’ existing products, the company reached a deal in mid-2108 to sell the firm back to its inspiring founders.
Now, the new independent firms visit Withings at CES 2019 with a brand new lineup of products led by the Move and Move ECG wearables. Like other wearables in the markets, the new ones from Withings can measure steps, sleep, and workout metrics from walking, running, swimming, and cycling.
Withings Move Smartwacth
The new Move from Withings comes at $70, and the shipments will embark in February. There will be five different colors that will target the youth. The company says that it will release new colors approaching monthly basis. By the end of the year, Withings will allow you to customize every aspect of the watch. You can swap the shades of the aluminum body to the strap and color of the dials. For now, the watch is available in delightful aqua-and-white and red-and-white color options.
The company claims a whopping 18-month battery on the watch, but that’s not all we’ve got.
Withings Move ECG Smartwatch
The Move ECG is another watch that has the same basic design as its cheaper counterpart, but it can measure one’s heart rhythm. The concept is similar to the one we’ve got to see with Apple Watch Serie 4. The Move ECG does this with the help of three electrodes.
The Move ECG has no screen, so it synchronizes the metrics from the watch with an iOS or Android app. According to Withings, the ECG functionality is still under review by the FDA. Unlike the cheaper variant, the Move ECG will provide 12-month battery life. Now, that is because of the additional ECG functionality on the watch. Once can change the battery easily with the standard watch cell.
The Move will embark its sales on February 5 for $69.95, while Move ECG comes a few weeks later, in Q2, for $129.95.